1. Home
  2. WYFI vs IMNM Comparison

WYFI vs IMNM Comparison

Compare WYFI & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WYFI
  • IMNM
  • Stock Information
  • Founded
  • WYFI 2023
  • IMNM 2006
  • Country
  • WYFI United States
  • IMNM United States
  • Employees
  • WYFI N/A
  • IMNM N/A
  • Industry
  • WYFI Finance: Consumer Services
  • IMNM Medicinal Chemicals and Botanical Products
  • Sector
  • WYFI Finance
  • IMNM Health Care
  • Exchange
  • WYFI Nasdaq
  • IMNM Nasdaq
  • Market Cap
  • WYFI 1.2B
  • IMNM 1.2B
  • IPO Year
  • WYFI 2025
  • IMNM 2020
  • Fundamental
  • Price
  • WYFI $34.54
  • IMNM $16.39
  • Analyst Decision
  • WYFI Strong Buy
  • IMNM Strong Buy
  • Analyst Count
  • WYFI 6
  • IMNM 9
  • Target Price
  • WYFI $31.17
  • IMNM $24.89
  • AVG Volume (30 Days)
  • WYFI 1.4M
  • IMNM 1.4M
  • Earning Date
  • WYFI 12-09-2025
  • IMNM 11-12-2025
  • Dividend Yield
  • WYFI N/A
  • IMNM N/A
  • EPS Growth
  • WYFI N/A
  • IMNM N/A
  • EPS
  • WYFI N/A
  • IMNM N/A
  • Revenue
  • WYFI $62,303,715.00
  • IMNM $12,589,000.00
  • Revenue This Year
  • WYFI $84.38
  • IMNM N/A
  • Revenue Next Year
  • WYFI $129.28
  • IMNM $85.68
  • P/E Ratio
  • WYFI N/A
  • IMNM N/A
  • Revenue Growth
  • WYFI N/A
  • IMNM 16.74
  • 52 Week Low
  • WYFI $14.01
  • IMNM $5.15
  • 52 Week High
  • WYFI $40.75
  • IMNM $17.32
  • Technical
  • Relative Strength Index (RSI)
  • WYFI N/A
  • IMNM 66.09
  • Support Level
  • WYFI N/A
  • IMNM $15.35
  • Resistance Level
  • WYFI N/A
  • IMNM $16.40
  • Average True Range (ATR)
  • WYFI 0.00
  • IMNM 1.10
  • MACD
  • WYFI 0.00
  • IMNM 0.00
  • Stochastic Oscillator
  • WYFI 0.00
  • IMNM 75.79

About WYFI WhiteFiber Inc. Ordinary Shares

Whitefiber Inc is a provider of artificial intelligence infrastructure solutions. The company owns high-performance computing data centers and provide cloud-based HPC graphics processing units services, which it terms cloud services, for customers such as AI application and machine learning developers. Its Tier-3 data centers provide hosting and colocation services. Its cloud services support generative AI workstreams, especially training and inference. It has two reportable segments: cloud services and colocation services. The cloud services segment generates revenue from providing high performance computing services to support generative AI workstreams. Colocation services generate revenue by providing customers with physical space, power and cooling within the data center facility.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: